Wells Fargo & Company MN grew its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 1.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,165,035 shares of the company's stock after purchasing an additional 14,794 shares during the period. Wells Fargo & Company MN owned approximately 0.26% of GE HealthCare Technologies worth $91,082,000 at the end of the most recent quarter.
A number of other institutional investors also recently modified their holdings of GEHC. Prudential PLC lifted its position in shares of GE HealthCare Technologies by 48.9% in the fourth quarter. Prudential PLC now owns 10,719 shares of the company's stock worth $838,000 after purchasing an additional 3,519 shares in the last quarter. World Investment Advisors lifted its position in GE HealthCare Technologies by 6.3% during the 4th quarter. World Investment Advisors now owns 5,012 shares of the company's stock worth $392,000 after buying an additional 296 shares in the last quarter. Westpac Banking Corp lifted its position in GE HealthCare Technologies by 25.1% during the 4th quarter. Westpac Banking Corp now owns 2,879 shares of the company's stock worth $225,000 after buying an additional 578 shares in the last quarter. Massachusetts Financial Services Co. MA grew its holdings in shares of GE HealthCare Technologies by 31.3% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 1,310,631 shares of the company's stock valued at $102,465,000 after acquiring an additional 312,088 shares in the last quarter. Finally, Trexquant Investment LP bought a new position in shares of GE HealthCare Technologies in the 4th quarter valued at about $4,797,000. 82.06% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Several brokerages recently commented on GEHC. Jefferies Financial Group raised GE HealthCare Technologies from a "hold" rating to a "buy" rating and increased their price target for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. Wells Fargo & Company raised their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a research note on Friday, February 14th. The Goldman Sachs Group raised shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and upped their price target for the stock from $85.00 to $100.00 in a research report on Tuesday, March 11th. Finally, Citigroup lifted their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a research report on Thursday, February 13th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $97.73.
Check Out Our Latest Analysis on GE HealthCare Technologies
GE HealthCare Technologies Stock Up 0.9 %
NASDAQ:GEHC traded up $0.53 during trading hours on Friday, hitting $62.81. 7,219,909 shares of the company traded hands, compared to its average volume of 3,127,495. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The company has a market cap of $28.72 billion, a PE ratio of 14.51, a PEG ratio of 3.19 and a beta of 1.14. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80. The firm's 50-day simple moving average is $81.75 and its 200-day simple moving average is $84.00.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping analysts' consensus estimates of $1.26 by $0.19. The firm had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. Equities analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.
GE HealthCare Technologies Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be paid a $0.035 dividend. The ex-dividend date is Friday, April 25th. This represents a $0.14 dividend on an annualized basis and a yield of 0.22%. GE HealthCare Technologies's dividend payout ratio (DPR) is currently 3.23%.
About GE HealthCare Technologies
(
Free Report)
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Featured Stories
Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
